Last reviewed · How we verify
WE 941 OD tablets
At a glance
| Generic name | WE 941 OD tablets |
|---|---|
| Sponsor | Boehringer Ingelheim |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pharmacological Study on Absorption of WE 941 OD Tablets in Japanese Healthy Male Volunteers (PHASE1)
- Bioequivalence Between WE 941 OD and Brotizolam (Lendormin®) Taken With Water in Healthy Adult Males (PHASE1)
- Bioequivalence Between WE 941 OD and Brotizolam (Lendormin®) in Healthy Adult Males (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |